Analyst Consensus ?
ConsensusHold33 ratings
Bullish1236.4%
Neutral1854.5%
Bearish39.1%
FN2 Earnings Intelligence
Quest Diagnostics Incorporated analyst ratings
Quest Diagnostics Incorporated (DGX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$234.3Current
$125Low
$195.29Average
$260High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Jul 28, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 24, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 8, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Feb 10, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 27, 2025 |
| Leerink Partners | Outperform | Outperform | Maintain | Oct 21, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 23, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Dec 17, 2024 |
| B of A Securities | Buy | Buy | Maintain | Dec 13, 2024 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Feb 3, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Dec 13, 2021 |
| Argus Research | Buy | Hold | Upgrade | Oct 21, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 21, 2020 |
| CFRA | Hold | Strong Buy | Downgrade | Apr 22, 2020 |
| Bank of America | Neutral | Underperform | Upgrade | Dec 19, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 24, 2019 |
| Goldman Sachs | Sell | Neutral | Downgrade | Jul 15, 2019 |
| Argus | Hold | Buy | Downgrade | Jan 31, 2019 |
| William Blair | Outperform | Market Perform | Upgrade | Jun 8, 2018 |
| Raymond James | Market Perform | Outperform | Downgrade | Sep 25, 2017 |
| Jyske Bank | Sell | Sell | Maintain | Jun 24, 2016 |
| JMP Securities | Perform | Market Perform | Maintain | Mar 27, 2015 |
| ISI Group | Neutral | Neutral | Maintain | Nov 19, 2013 |
| Craig-Hallum | Buy | Buy | Maintain | Sep 19, 2013 |
| Maxim Group | Buy | Hold | Upgrade | Aug 8, 2013 |
| Oppenheimer | Underperform | Underperform | Maintain | Jan 28, 2013 |
| Macquarie | Neutral | Underperform | Upgrade | Nov 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $234.3. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $260 | $235.34 | +11.0% | Jul 29, 2026 |
| UBS | Kevin Caliendo | $232 | $231.3 | -1.0% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $255 | $227.9 | +8.8% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $250 | $227.9 | +6.7% | Jul 23, 2026 |
| Jefferies | Analyst unavailable | $245 | $227.9 | +4.6% | Jul 23, 2026 |
| Robert W. Baird | Analyst unavailable | $236 | $207.44 | +0.7% | Jul 13, 2026 |
| Evercore ISI | Analyst unavailable | $225 | $205.18 | -4.0% | Apr 21, 2026 |
| Jefferies | Analyst unavailable | $225 | $205.18 | -4.0% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $210 | $198.81 | -10.4% | Apr 8, 2026 |
| Mizuho Securities | Analyst unavailable | $235 | $209.32 | +0.3% | Feb 12, 2026 |
| UBS | Analyst unavailable | $210 | $206.72 | -10.4% | Feb 11, 2026 |
| Truist Financial | Analyst unavailable | $220 | $205.62 | -6.1% | Feb 11, 2026 |
| Evercore ISI | Elizabeth Anderson | $220 | $205.43 | -6.1% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $219 | $205.35 | -6.5% | Feb 11, 2026 |
| Jefferies | Tycho Peterson | $220 | $205.24 | -6.1% | Feb 10, 2026 |
| Barclays | Analyst unavailable | $210 | $182.35 | -10.4% | Jan 30, 2026 |
| Piper Sandler | Analyst unavailable | $200 | $182.18 | -14.6% | Oct 27, 2025 |
| Truist Financial | Analyst unavailable | $205 | $184.64 | -12.5% | Oct 22, 2025 |
| Morgan Stanley | Erin Wright | $207 | $183.18 | -11.7% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $195 | $183.18 | -16.8% | Oct 22, 2025 |
| Jefferies | Analyst unavailable | $215 | $183.34 | -8.2% | Oct 21, 2025 |
| Leerink Partners | Analyst unavailable | $210 | $184.1 | -10.4% | Oct 21, 2025 |
| UBS | Kevin Caliendo | $190 | $186.82 | -18.9% | Oct 17, 2025 |
| Mizuho Securities | Analyst unavailable | $210 | $186.82 | -10.4% | Oct 17, 2025 |
| Truist Financial | Analyst unavailable | $195 | $184 | -16.8% | Oct 14, 2025 |
| Evercore ISI | Analyst unavailable | $190 | $181.89 | -18.9% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $190 | $182.07 | -18.9% | Oct 2, 2025 |
| Robert W. Baird | Analyst unavailable | $194 | $178.66 | -17.2% | Aug 25, 2025 |
| Evercore ISI | Elizabeth Anderson | $185 | $170.48 | -21.0% | Jul 23, 2025 |
| Redburn Partners | Jamie Clark | $195 | $167.96 | -16.8% | Apr 2, 2025 |
| Piper Sandler | David Westenberg | $180 | $162.47 | -23.2% | Feb 3, 2025 |
| Truist Financial | David MacDonald | $182 | $163.1 | -22.3% | Jan 31, 2025 |
| Robert W. Baird | Eric Coldwell | $189 | $163.1 | -19.3% | Jan 31, 2025 |
| Citigroup | Patrick Donnelly | $185 | $157.47 | -21.0% | Oct 23, 2024 |
| Leerink Partners | Michael Cherny | $165 | $157.47 | -29.6% | Oct 23, 2024 |
| Barclays | Stephanie Davis | $168 | $157.47 | -28.3% | Oct 23, 2024 |
| Robert W. Baird | Eric Coldwell | $182 | $157.47 | -22.3% | Oct 23, 2024 |
| CFRA | Paige Meyer | $178 | $157.46 | -24.0% | Oct 22, 2024 |
| Truist Financial | David MacDonald | $165 | $150.79 | -29.6% | Oct 7, 2024 |
| Mizuho Securities | Ann Hynes | $160 | $143.21 | -31.7% | Jul 29, 2024 |
| Robert W. Baird | Eric Coldwell | $154 | $140.96 | -34.3% | Jul 24, 2024 |
| Truist Financial | David MacDonald | $158 | $144.11 | -32.6% | Jul 15, 2024 |
| Barclays | Stephanie Davis | $144 | $137.55 | -38.5% | Apr 25, 2024 |
| Jefferies | Brian Tanquilut | $155 | $127.42 | -33.8% | Feb 7, 2024 |
| Wells Fargo | Analyst unavailable | $140 | $143.29 | -40.2% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $158 | $155.5 | -32.6% | Jan 6, 2023 |
| Citigroup | Analyst unavailable | $125 | $149.27 | -46.6% | Nov 17, 2022 |
| Morgan Stanley | Analyst unavailable | $142 | $136.13 | -39.4% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $150 | $133.75 | -36.0% | Apr 25, 2022 |
| Citigroup | Ralph Giacobbe | $175 | $140 | -25.3% | Apr 9, 2022 |
| Deutsche Bank | Pito Chickering | $190 | $142.3 | -18.9% | Jan 15, 2022 |
| KeyBanc | Donald Hooker | $170 | $161.75 | -27.4% | Dec 13, 2021 |
| Credit Suisse | A.J. Rice | $150 | $155.22 | -36.0% | Sep 9, 2021 |
Track every rating change on DGX the moment it posts. Free to start.
Start free